Dragon Pharma ARA-290 16 mg
Dragon Pharma's ARA-290 16 mg is a cutting-edge synthetic peptide that represents one of the most significant advancements in neuroprotection and tissue repair research. Also known as cibinetide, this 11-amino-acid peptide is derived from erythropoietin (EPO) but has been specifically engineered to activate the innate repair receptor (IRR) without the erythropoietic effects that increase red blood cell production. This unique selectivity makes ARA-290 a remarkable compound for promoting nerve repair, reducing inflammation, and supporting tissue healing without the cardiovascular risks associated with traditional EPO.
The mechanism of action of ARA-290 is both elegant and highly targeted. The peptide binds to a specific receptor complex known as the innate repair receptor, which is expressed on various tissues including neurons, glial cells, and vascular endothelial cells. Upon binding, ARA-290 activates a cascade of signaling pathways that promote tissue protection, reduce inflammation, and stimulate repair processes. Unlike EPO, which primarily stimulates red blood cell production through the classical EPO receptor, ARA-290's selectivity for the IRR allows it to exert its beneficial effects without the erythropoietic activity that can increase blood viscosity and cardiovascular risk.
For bodybuilders and athletes, the nerve repair and anti-inflammatory properties of ARA-290 are of particular significance. Intense training, injuries, and the use of certain compounds can lead to nerve damage, chronic pain, and neuropathies that impair performance and quality of life. ARA-290 has been extensively studied for its ability to promote nerve fiber repair and reduce neuropathic pain, making it a valuable tool for athletes dealing with nerve-related injuries or chronic pain conditions.
The peptide's anti-inflammatory effects are equally important for athletes. Chronic inflammation is a common issue in sports, resulting from repetitive stress, microtrauma, and the body's response to intense training. ARA-290 modulates inflammatory responses by promoting the resolution of inflammation and reducing the production of pro-inflammatory cytokines. This balanced anti-inflammatory action supports recovery, reduces pain, and helps athletes maintain optimal training intensity and frequency.
Perhaps one of the most significant advantages of ARA-290 is its ability to promote nerve repair without the side effects associated with traditional EPO. While EPO can increase the risk of blood clots, hypertension, and stroke due to its erythropoietic effects, ARA-290's targeted mechanism avoids these risks entirely. This makes it a much safer option for athletes seeking the neuroprotective and tissue repair benefits of EPO without the dangerous side effects.
Research on ARA-290 has demonstrated remarkable results in various clinical settings. The peptide has shown significant efficacy in reducing pain and improving nerve function in patients with neuropathies, including those with sarcoidosis and chemotherapy-induced neuropathy. For athletes, this translates to potential benefits such as improved nerve function, reduced pain from nerve injuries, enhanced recovery from training, and better overall tissue health.
ARA-290's effects on tissue repair extend beyond the nervous system. The peptide has been shown to promote wound healing, reduce inflammation in various tissues, and support the repair of damaged cells. For athletes recovering from injuries or dealing with chronic tissue damage, ARA-290 offers a research-based approach to supporting the body's natural healing processes.
The development of ARA-290 represents a significant breakthrough in peptide science. By selectively activating the innate repair receptor, this peptide harnesses the body's natural repair mechanisms without the risks associated with broader receptor activation. This precision makes ARA-290 a valuable tool for athletes and individuals seeking targeted support for nerve health, inflammation reduction, and tissue repair.
Key Benefits:
- Nerve Fiber Repair: Promotes repair and regeneration of damaged nerve fibers, supporting recovery from neuropathies and nerve injuries common in sports.
- Anti-Inflammatory Action: Modulates inflammatory responses and promotes resolution of chronic inflammation, reducing pain and supporting recovery.
- Innate Repair Receptor Activation: Selectively activates the IRR without erythropoietic effects, providing targeted tissue repair without cardiovascular risks.
- Pain Reduction: Demonstrates significant efficacy in reducing neuropathic pain, supporting athletes dealing with chronic pain conditions.
- EPO Benefits Without Risks: Provides the neuroprotective and tissue repair benefits of EPO without the dangerous erythropoietic side effects, making it a safer alternative.
Each package contains one 2 mL glass vial with 16 mg of lyophilized ARA-290 powder, manufactured under strict quality control standards in Dragon Pharma's certified European facilities. The product requires reconstitution with bacteriostatic water prior to use.
Product Specifications
| Product Name |
ARA-290 16 mg |
| Manufacturer |
Dragon Pharma |
| Substance |
ARA-290 (Cibinetide) |
| Packaging |
2 mL Glass Vial (Lyophilized Powder) |
| Lab Test Result |
HPLC Verified (≥98% Purity) |
| Half-Life |
Approximately 4-6 hours |
| Recommended Cycle |
4-8 Weeks |
| Form |
Lyophilized Powder |
| Aromatization |
No |
| Dosage (Men) |
100-300 mcg per day |
Usage Guidelines
ARA-290 is typically administered via subcutaneous injection after reconstitution with bacteriostatic water. Based on clinical research and user experience, the following protocols have shown effectiveness for nerve repair and inflammation reduction.
- Beginner Protocol: 100 mcg administered once daily for 4 weeks. This dosage is recommended for first-time users to assess tolerance and initial nerve repair benefits.
- Intermediate Protocol: 150-200 mcg daily for 6 weeks. This is the most common protocol for neuropathy support, nerve repair, and inflammation reduction.
- Advanced Protocol: 300 mcg daily, divided into two doses (morning and evening), for 8 weeks. This protocol is for those seeking maximum neuroprotective and tissue repair benefits.
Recommended Stacking Strategies:
ARA-290 can be effectively combined with other Dragon Pharma products for comprehensive nerve and tissue repair support. For enhanced tissue regeneration and recovery, stacking with BPC-157 5 mg provides synergistic healing benefits. For those seeking comprehensive inflammation reduction and tissue support, TB-500 5 mg offers complementary regenerative effects. For enhanced cognitive and neurological support, combining with Semax 5 mg can amplify neuroprotective benefits. For users focused on mitochondrial health and energy optimization, SS-31 50 mg pairs well with ARA-290's tissue repair properties.
Health & Ancillary Support:
While ARA-290 does not affect erythropoiesis or hormonal pathways directly, maintaining overall health is essential for optimal results. For athletes using anabolic steroids, comprehensive cardiovascular support is recommended—consider incorporating Atorvastatin 40 mg for lipid management. Additionally, proper nutrition, adequate sleep, stress management, and a nutrient-dense diet rich in antioxidants are crucial to maximizing the benefits of this neuroprotective peptide.
Storage Instructions
Proper storage is essential to maintain the integrity and potency of ARA-290.
- Lyophilized Powder: Store in a cool, dry place away from direct light at room temperature (up to 25°C / 77°F).
- Post-Reconstitution: Once mixed with bacteriostatic water, the solution must be refrigerated at 2-8°C (36-46°F).
- Stability: Use the reconstituted solution within 28-30 days to ensure optimal peptide efficacy.
- Important: Do not freeze the reconstituted solution, as this can degrade the peptide structure.
Frequently Asked Questions
What is ARA-290 and how does it work?
ARA-290 (cibinetide) is an 11-amino-acid synthetic peptide derived from erythropoietin. It selectively activates the innate repair receptor (IRR) to promote nerve fiber repair, reduce inflammation, and support tissue healing. Unlike EPO, it does not stimulate red blood cell production, making it safer with fewer cardiovascular risks.
How do I reconstitute ARA-290 16 mg?
To reconstitute ARA-290, add 2 mL of bacteriostatic water to the vial. Gently swirl until the powder is fully dissolved. Avoid shaking vigorously. This yields a concentration of 8 mg/mL for accurate dosing. Always use sterile techniques and equipment.
What are the recommended dosages for ARA-290?
Based on clinical research and user experience, common dosages range from 100-300 mcg per day. Beginners should start at 100 mcg daily for 4 weeks, while more advanced users may work up to 300 mcg per day for 8 weeks. Always start with the lowest effective dose and monitor your response.
Can ARA-290 be stacked with other peptides?
Yes, ARA-290 stacks effectively with other peptides for enhanced nerve and tissue repair benefits. Common combinations include BPC-157 for tissue healing, TB-500 for regeneration, Semax for cognitive support, and SS-31 for mitochondrial health. Always research compatibility and use appropriate cycling protocols.
What are the benefits of ARA-290 for bodybuilders and athletes?
ARA-290 offers several benefits for athletes: promotes nerve fiber repair for recovery from neuropathies and nerve injuries, reduces chronic inflammation that impairs recovery, provides targeted tissue repair without cardiovascular risks, reduces neuropathic pain, and supports overall healing from injuries and training stress. This makes it particularly valuable for athletes dealing with nerve-related issues, chronic pain, or recovery from injuries.
